Cargando…
Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies
Pediatric-onset multiple sclerosis (MS) comprises approximately 3%–5% of cases of MS in North America. Recent years have seen significant advances in the diagnosis and treatment of this condition, including the introduction of proposed diagnostic criteria for pediatric demyelinating disorders, and a...
Autor principal: | Yeh, E Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916074/ https://www.ncbi.nlm.nih.gov/pubmed/24600262 |
Ejemplares similares
-
Current and Future Therapies for Multiple Sclerosis
por: Minagar, Alireza
Publicado: (2013) -
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
por: Margoni, Monica, et al.
Publicado: (2021) -
A Scoping Review of Modifiable Risk Factors in Pediatric Onset Multiple Sclerosis: Building for the Future
por: Pétrin, Julie, et al.
Publicado: (2018) -
Multiple Sclerosis in Pediatrics: Current Concepts and Treatment Options
por: Jancic, Jasna, et al.
Publicado: (2016) -
Current and Future Biomarkers in Multiple Sclerosis
por: Yang, Jennifer, et al.
Publicado: (2022)